Related Experiment Video
Updated: May 12, 2025

09:21
A Triple Culture Cell System Modeling the Human Blood-Brain Barrier
Published on: November 30, 2021
3.4K
A Biomimetic Human Multi-Cellular In Vitro Model of the Blood-Brain Barrier
John Saliba1,2, Jessica Saliba3,4, Marwan El-Sabban1
1Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.
International Journal of Molecular Sciences
|May 7, 2025
Summary
A new 3D hydrogel model using human cells effectively mimics the blood-brain barrier (BBB). This advanced platform enhances the study of central nervous system diseases and drug permeability across the BBB.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Cell Biology
Background:
- Current in vitro models inadequately replicate the human blood-brain barrier (BBB) physiology.
- A reliable BBB model is crucial for studying central nervous system (CNS) diseases and drug permeability.
Purpose of the Study:
- To develop a 3D co-culture model using primary human cells to better mimic the human BBB.
- To assess the barrier function and physiological relevance of the developed model.
Main Methods:
- Co-culture of primary human astrocytes (A) and endothelial cells (HAECs) within a gelatin methacrylate (GelMA) hydrogel scaffold.
- Assessment of tight junction marker expression (CLDN5, CDH1).
- Measurement of trans-endothelial electrical resistance (TEER) and Evans blue albumin (EBA) permeability.
Main Results:
- The 3D HAEC+A co-culture showed a 12-fold increase in CLDN5 and CDH1 expression compared to 2D models.
- The 3D HAEC+A model achieved the highest TEER (45 Ω·cm²), significantly higher than 2D or 3D HAEC-only cultures.
- This 3D model exhibited significantly lower EBA permeability, indicating enhanced barrier function.
Conclusions:
- The developed 3D co-culture model effectively replicates key physiological features of the human BBB in vitro.
- This model provides a robust platform for investigating BBB permeability to drugs, cells, and pathogens.
- The model holds promise for advancing research in CNS diseases and therapeutic development.

